One Zyme watches the entire biopharma landscape for the signals that precede a buying decision — financings, new programs, trial starts, regulatory milestones — and surfaces the highest-fit prospects at just the right moment.
I can't live without One Zyme.
Define the events that matter to your business once. One Zyme then monitors every sponsor you want to target and alerts your team when a buying trigger fires, with the context and the right contact already attached.
Series A through crossover and IPO, capital is the clearest signal that programs are about to move.
First-in-human starts, new indications, and freshly disclosed preclinical programs as they appear.
IND clearances, Fast Track and Orphan designations, and other FDA/EMA actions that reset timelines.
New alliances, licensing deals, and M&A that change who holds the budget, and who you should be calling.
Most prospecting starts the day a trial posts, when every CRO is already calling. One Zyme reads the upstream signals and scores which sponsors are most likely to enter the clinic next, so your team is in the room weeks early.
One Zyme combines financing, hiring, regulatory, scientific, and pipeline signals into a single likelihood score for every sponsor, ranked by how close they are to the moment they'll need a CRO, manufacturer, or service partner.
Instead of chasing trials the day they post, your team gets a prioritized, continuously-updated list of who's coming next.
Boost your conference ROI. One Zyme scores the full attendee and sponsor list against your buying triggers, ranks who's worth your time, and drafts a tailored opener for each, grounded in the exact signal that makes them a fit right now.
Hi Sarah, congratulations on the Series B and the new ADC program. As you scale toward IND-enabling studies, payload-linker analytics and GMP conjugation capacity tend to become the gating step.
We've supported three peptide-ADC sponsors through exactly this transition this year, would 20 minutes at ASCO be useful to compare notes?
Reps piece together Zymewire, GlobalData, Citeline, SciLeads, and a dozen open browser tabs to build a single account view. One Zyme replaces all of it with one dynamic intelligence layer, tuned to how your team actually sells.
One Zyme has been an excellent partner. The team is proactive, responsive, and always eager to solve challenges. I genuinely feel that my feedback is heard and acted upon.
The platform’s market intelligence and ability to generate market reports at the click of a button provide valuable insights that help us identify opportunities faster and make better informed decisions.
However, what excites me most is their continuous innovation. I’m always looking forward to hearing from Aaron about the next new thing and seeing how the platform continues to evolve.
The reps who win consistently have the deepest understanding of their customers. One Zyme hands your team a living dossier on every target: the full pipeline, the science behind it, and the competitive context, so every conversation lands on the details that matter to them.
Every asset the sponsor is running, by phase, modality, and indication, so your team sees exactly where your services fit and where the next need is forming.
Who else is chasing the same target, where the account is ahead or behind, and the pressure shaping their timelines, the backdrop that makes your pitch relevant right now.
Walk in already briefed on the pipeline, the science, and the competition, and every conversation moves faster, earns more trust, and closes at a higher rate.
One Zyme turns the same intelligence into segments and messaging your marketing team can act on: who to target, what they care about right now, and the message that will land.
Build audiences from real buying signals, recently financed, entering the clinic, new modality, that refresh automatically as the landscape moves.
Each segment gets messaging grounded in why it's a fit right now, the modality, the milestone, the gap your service fills, instead of one generic blast.
Every segment and claim traces back to a cited source, so sales and marketing speak from the same evidence, and reps walk into calls already briefed.
Get a strategic briefing tailored to your services, target modalities, and territories, and see the buying triggers firing across your market right now.
